0001753926-21-000252.txt : 20210713
0001753926-21-000252.hdr.sgml : 20210713
20210713164514
ACCESSION NUMBER: 0001753926-21-000252
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210713
DATE AS OF CHANGE: 20210713
EFFECTIVENESS DATE: 20210713
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Predictive Health Diagnostics Co.
CENTRAL INDEX KEY: 0001694554
IRS NUMBER: 814578409
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-406096
FILM NUMBER: 211088377
BUSINESS ADDRESS:
STREET 1: 510 VIA DELFIN
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 9495473140
MAIL ADDRESS:
STREET 1: 510 VIA DELFIN
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
D
1
primary_doc.xml
X0708
D
LIVE
0001694554
Predictive Health Diagnostics Co.
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
866-299-8998
DELAWARE
None
None
Corporation
true
2016
Matthew
Nunez
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
Executive Officer
Director
Douglas
Harrington
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
Director
Estrella
Harrington
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
Director
Suzy
Lu
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
Director
Munira
al Delemi
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
Director
Yonghong
Wu
13885 ALTON PARKWAY, SUITE B
IRVINE
CA
CALIFORNIA
92618
Director
Other Health Care
Decline to Disclose
- 06b
false
2021-02-25
false
true
false
10000
Boustead Securities
141391
None
None
6 VENTURE, SUITE 395
IRVINE
CA
CALIFORNIA
92618
All States
false
8307000
8307000
0
false
66
430990
0
Boustead Securities were issued warrants to purchase up to 172,396 shares of Series A Preferred Stock of the Company with an exercise price of $2.50 per share in connection with its placement agent services in this offering.
0
false
Predictive Health Diagnostics Co.
/s/ Matthew Nunez
Matthew Nunez
Chief Executive Officer
2021-07-12